NCT01919944 Study of Itch Control by VLY-686 in Healthy Volunteers After Intradermal Injections of Substance P Status COMPLETED Phase PHASE1
NCT01905631 Blinded, Randomized Study Evaluating Aurstat Versus Control in the Treatment of Atopic Dermatitis Associated Pruritus Status COMPLETED Phase PHASE2
NCT01897428 PK Comparisons of Bepotastine Besilate 10 mg and Bepotastine Salicylate 9.64 mg Status COMPLETED Phase PHASE1
NCT01825655 Study of Using Long Acting Antihistamine to Treat Opioid Induced Itching Status TERMINATED Phase PHASE4
NCT01801670 Impact of Vorinostat on Pruritus Signaling Pathways - Merck Study Status WITHDRAWN Phase N/A
NCT01795079 Effects of Transcranial Direct Current Stimulation (tDCS) on Neuropathic Symptoms Following Burn Injury Status COMPLETED Phase NA
NCT01769144 Acticoat Absorbent and BCT Antimicrobial for STSG Donor Site on Thigh Status UNKNOWN Phase NA
NCT01625455 Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome Status TERMINATED Phase PHASE4
NCT01605708 Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis Status TERMINATED Phase PHASE1/PHASE2
NCT01265082 Explore the Mechanisms of Pruritus in Bullous Pemphigoid Patients During Remission Status UNKNOWN Phase N/A
NCT01236859 Gabapentin for Prophylaxis Intrathecal Morphine-Induced Pruritus Status COMPLETED Phase NA
NCT01232985 Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults Status COMPLETED Phase PHASE2
NCT01092520 Gabapentin for the Treatment of Pruritus Caused by Burn Injuries in Children Status WITHDRAWN Phase PHASE1
NCT01071057 Naloxone for the Treatment of Opioid-Induced Pruritus Status COMPLETED Phase PHASE2/PHASE3
NCT01055236 Hydroxyzine for the Prevention of Pruritus From Spinal Morphine in Transabdominal Hysterectomy Patients Status COMPLETED Phase PHASE4